ArticleClinical and experimental medicine2023

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement.

Francesco Iannazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.